Paracervical Block During II-trimester Abortion

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

112 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-05-31

Study Completion Date

2015-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Paracervical blockage can reduce severe pain during second trimester induced medical abortion.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Paracervical Block for Pain Control in First Trimester Abortion

NCT01094366

Legal Abortion With Complication Pain

COMPLETED PHASE4

Cervical Preparation of Abortions Under Paracervical Block in the First Trimester:

NCT03043014

Surgical Abortion

COMPLETED NA

Paracervical Block in First Trimester Surgical Abortions

NCT00617097

Pain Surgical Abortion

COMPLETED PHASE2/PHASE3

Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion

NCT01466491

Pain

COMPLETED PHASE4

Cervical Preparation Before Dilation and Evacuation

NCT01751087

Abortion, Induced

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Second Trimester Medical Abortion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bupivacain

Group Type ACTIVE_COMPARATOR

bipuvacain

Intervention Type DRUG

PCB with 20ml bupivakain or sodium cloride 9mg/ml will be administered one hour following misorpostol administration (first dose).

Sodium Chloride

Group Type SHAM_COMPARATOR

NaCl

Intervention Type OTHER

PCB with 20ml sodium chloride (9mg/ml) inactive (sham) comparator

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bipuvacain

PCB with 20ml bupivakain or sodium cloride 9mg/ml will be administered one hour following misorpostol administration (first dose).

Intervention Type DRUG

NaCl

PCB with 20ml sodium chloride (9mg/ml) inactive (sham) comparator

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

(Marcain® 2,5mg/ml)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who request second trimester medical abortion (13-22 weeks gestation according to ultrasound)
* 18 years of age or older
* able to understand and communicate in Swedish
* able to understand the study related information and willing to give her
* informed consent to participation in the study